Lung Cancer Test Kit

Use is advised for adults aged 40 years or older who are at an increased risk of developing cancer.

A methylated genes product has been developed by Lepu Medical for the detection of lung cancer.input:
output:The non-invasive diagnostic tests necessitate only a blood tube.input:
output:Description of the Diagnostic Kit for Methylated Genes in Lung Cancerinput:
output:The diagnostic kits for methylated genes of lung cancer are based on a blood-based test and incorporate proprietary epigenomics ctDNA methylation biomarkers to diagnose lung cancer, which is also referred to as abnormal gene epigenetic modification. As an auxiliary screening technique, lung cancer diagnostic kits can alleviate and prevent patient anxiety during periods of uncertain results, assist physicians in the clinical diagnosis of diseases, and provide physicians with a fast, accurate, and reliable method to diagnose cancer.input:
output:The Diagnostics kits can be employed to screen for lung cancer by identifying abnormal methylation levels of ctDNA. It is capable of predicting the development of cancer and monitoring cancer metastasis and recurrence.input:
output:The Diagnostics kits are applicable at distinct stages of cancer development.input:
output:Population Groups Suggestions for ScreeningSmoking history (including current or former smokers) or smoke exposure (passive smoking). Male and female individuals aged 40 and older.input:
output:A pulmonary nodule has been diagnosed.input:
output:Other lung diseases, such as chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis, have been diagnosed.input:
output:First-degree relatives with a family history of lung cancer.input:
output:Occupational exposures, particularly those that have been identified as containing targeted lung carcinogens.